The independent source for health policy research, polling, and news.
661-680 of 1,286 results
Patients soon will not have to worry about the prospect of these often-costly unexpected bills, a federal law promises. Some experts say the new policy could also slow the growth of health insurance premiums.
A 2017 law designed to help lower the cost of hearing aids mandated that federal officials set rules for a new class of devices consumers could buy without needing to see an audiologist. But those regulations are still on hold.
The Medicare rule, designed by the Trump administration to take money away from drug industry brokers and provide refunds to patients, has not been implemented. But budget analysts say if it were, it would cost the government money. So senators are pushing the rule aside and claiming to save billions of dollars, which they want to use instead on new projects.
State health officials say the federal government will likely reject any work or community engagement requirements, which were key to Republican lawmakers agreeing to extend the program that insures 100,000 low-income Montana adults.
A Trump administration rule mandating that hospitals disclose true prices on their websites took effect this year. But compliance is spotty and even when the data is public, it’s hard to find and understand.
The Biden administration is moving to undo many of the changes the Trump administration made to the enrollment process for the Affordable Care Act to encourage more people to sign up for health insurance. Meanwhile, Congress is opening investigations into the controversial approval by the Food and Drug Administration of an expensive drug that might (or might not) slow the progression of Alzheimer’s disease. Joanne Kenen of Politico, Kimberly Leonard of Insider and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Marshall Allen of ProPublica about his new book, “Never Pay the First Bill: And Other Ways to Fight the Health Care System and Win.”
The Biden administration has started to speed efforts to reverse health policies forged under Donald Trump. Most recently, the administration overturned a ban on fetal tissue research and canceled a last-minute extension of a Medicaid waiver for Texas. That latter move may delay the Senate confirmation of President Joe Biden’s nominee to head the Medicare and Medicaid programs, as Sen. John Cornyn (R-Texas) seeks to fight back. Anna Edney of Bloomberg News, Rachel Cohrs of Stat and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
A misguided federal program called the Unapproved Drugs Initiative, which put the FDA’s stamp of approval on old drugs, led to higher prices. It’s scrapped. So now what?
Return to pre-Trump policy is second win of the week for abortion-rights backers.
Dr. Robert Redfield, Trump’s CDC director, lends his scientific credibility to its Clean Air Systems subsidiary, which touts a “virus-killing ion technology” added to its fans. But indoor air quality experts question whether some of its technology works in the real world.
As The Guardian and KHN end Lost on the Frontline, a yearlong project to count health care worker deaths in the pandemic, the White House is under pressure to take up the task.
Indiana’s program seeks to give expansion enrollees “skin in the game,” requiring that they pay small monthly premiums and manage health savings accounts.
The little-used Congressional Review Act allows a new administration and Congress to fast-track the repeal of regulations and other executive actions of the previous administration. But neither lawmakers nor the president are making any attempt to use it now.
Air-cleaning companies with limited oversight are targeting a growing market of schools desperate for covid-19 protection. Donald Trump’s former covid adviser lands with one that built its business, in part, on ozone-emitting technology.
A Trump administration Medicare rule will push some hospital patients into a Catch-22: The government says several hundred procedures no longer need to be done in a hospital, but it did not approve them to be performed elsewhere. So patients will still need to use a hospital while not officially admitted — and may be charged more out-of-pocket for the care.
President Joe Biden may want to continue the previous administration’s efforts to lower drug prices and make medical costs transparent.
The Trump and Biden administrations both imposed wartime production requirements. But industry experts say the vast quantities of raw materials and specialty equipment needed for billions of newfangled vaccines have required herculean logistical efforts.
In the hours before President Joe Biden was inaugurated, the Federal Emergency Management Agency allowed a Texas mask maker to ship the high-quality masks overseas.
Inoculating the millions of undocumented workers who produce America’s agricultural bounty will be key to achieving herd immunity against covid-19. But garnering the trust of these workers is proving complicated, particularly in the South, where the last four years have been marked by workplace raids and anti-immigrant vitriol.
Those walking away free were facing years in prison for crimes of “unbounded greed.”
© 2026 KFF